Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT Trial

By sjmartinez • April 29, 2023

Khan MS, Singh S, Segar MW, Usman MS, Keshvani N, Ambrosy AP, Fiuzat M, Van Spall HGC, Fonarow GC, Zannad F, Felker GM, Januzzi JL Jr, O'Connor C, Butler J, Pandey A. Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT Trial. JACC Heart Fail. 2023 Apr 15:S2213-1779(23)00137-3. doi: 10.1016/j.jchf.2023.03.007. Epub ahead of print. PMID: 37115133.

Tags: Cardiology/Epi, GDMT, heart failure with reduced ejection fraction (HFrEF), Polypharmacy, Publications, triple therapy

Demographics and Trends of Sudden Cardiac Death-Related Mortality in the United States, 1999 to 2022

Jaiswal V, Kumar D, Mashkoor Y, Latif F, Kanagala SG, Halder A, Jaiswal A, Bandyopadhyay D, Hajra A, Joshi A, Aronow WS, Fonarow GC. Demographics[...]

Disparities in Heart Failure Epidemiology, Diagnosis, Management, and Outcomes

Yan AR, Srivastava PK, Vucicevic D, Agarwal MA, Ziaeian B, Fonarow GC, Nsair A, Shahandeh N. Disparities in Heart Failure Epidemiology, Diagnosis, Management, and Outcomes.[...]

Skin-adaptive focused flexible micromachined ultrasound transducers for wearable cardiovascular health monitoring

Yuan J, Li Z, Zhao Y, Luo R, Qin S, Li J, Li M, Han G, Li Z, Zhao Z, Li J, Zhang S, Yuan[...]